News

Actions

Worldwide Treatment for Depression

Posted: 11:42 AM, May 03, 2017
Updated: 2017-05-03 15:42:46Z

The GeneSight test helps healthcare providers make better treatment decisions based on a person’s genetic makeup. GeneSight testing is based on advanced CPGx® technology, a patented approach that analyzes variations and combinations of a person’s genes along with FDA-approved medications for behavioral health conditions and chronic pain.  Numerous peer-reviewed, published studies have proven its clinical benefits and substantial healthcare cost savings. More than 18,000 healthcare professionals have used GeneSight to improve healthcare for more than 500,000 patients. Learn more at www.GeneSight.com.